SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-542456
Filing Date
2016-04-15
Accepted
2016-04-15 09:04:06
Documents
11
Effectiveness Date
2016-04-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A d47562ddefa14a.htm DEFA14A 42327
2 GRAPHIC g47562naapg01a.jpg GRAPHIC 2021
3 GRAPHIC g47562naapg01bnew.jpg GRAPHIC 1382
4 GRAPHIC g47562naapg01cnew.jpg GRAPHIC 635
5 GRAPHIC g47562naapg02anew.jpg GRAPHIC 1451
6 GRAPHIC g47562naapg02b.jpg GRAPHIC 1202
7 GRAPHIC g47562naapg02cnew.jpg GRAPHIC 1197
8 GRAPHIC g47562naapg02dnew.jpg GRAPHIC 1304
9 GRAPHIC g47562naapg02enew.jpg GRAPHIC 634
10 GRAPHIC g47562naapg03new.jpg GRAPHIC 634
11 GRAPHIC g47562naapg04.jpg GRAPHIC 754
  Complete submission text file 0001193125-16-542456.txt   60401
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 161573273
SIC: 2836 Biological Products, (No Diagnostic Substances)